| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/03/2002 | US20020002204 Blowing nitrogen gas through a hollow cylinder of an oxygen permeable plastic, molding the hollow cylinder into an oxygen permeable container, filling the container with aqueous albuterol or salt free of albuterol aldehyde and oxygen |
| 01/03/2002 | US20020002203 Administering an effective amount of a compound selected from aryl(and heterocyclic) ureido and aryl(heterocyclic) carboxamido phenoxyisobutyric acids as inhibitor of glycation and advanced glycation endproducts (AGEs) (protein-aging) |
| 01/03/2002 | US20020002202 L-carnitine fumarate or alkanoyl L- carnitine fumarate is useful for reducing, in a broad range of users and/or patients, the risk of onset of organ ishcemia, and for preventing and/or therapeutically treating it |
| 01/03/2002 | US20020002201 Administering to a mammal a therapeutically effective amount of 4-ethylamino-2-butynyl cyclohexyl-phenylglycolate and/ or one or more optically active isomers, and salts to treat disorders involving the urethrogenital tract |
| 01/03/2002 | US20020002200 Novel diphenylethylene compounds |
| 01/03/2002 | US20020002198 Growth hormone (GH) release in vertebrates may be augmented by an oral dietary supplement composed of acetyl-l-carnitine and an amino acid selected from l-ornithine, l-lysine, l-arginine, l-histidine, l-valine, l-phenylalanine, l-leucine etc |
| 01/03/2002 | US20020002197 Tropisetron, Fabesetron, Ramosetron and other drugs useful for treatment of a non-inflammatory local disease of the musculo-sceletal system, of a local irritation condition of a joint or tendom sheath or local manifestation |
| 01/03/2002 | US20020002196 Administering a patient an effective amount of hydroxyeicosatetraenoic acid related compounds to treat the dry eye |
| 01/03/2002 | US20020002194 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 01/03/2002 | US20020002191 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | US20020002189 Nicotine therapy method and oral carrier for assuaging tobacco-addiction |
| 01/03/2002 | US20020002186 Pharmaceutical composition |
| 01/03/2002 | US20020002185 Compositions and methods for reducing ocular hypertension |
| 01/03/2002 | US20020002184 Novel process and compound |
| 01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
| 01/03/2002 | US20020002182 Cis-substituted aminocyclopropane derivatives |
| 01/03/2002 | US20020002181 Use of leptin antagonists for the treatment of diabetes |
| 01/03/2002 | US20020002180 A synergistic mixture of lamivudine and BMS-200475 for the treatment of a Hepititis B viral infection; effective against mutants resistant to nucleoside and/or non-nucleoside inhibitors of the replication of the HBV |
| 01/03/2002 | US20020002179 Terazosin in the chronic treatment of the urinary symptoms associated with benign prostatic hyperplasia |
| 01/03/2002 | US20020002178 Antiproliferative, -carcinogenic agents, antiinflammatory and -arthritis agents; neurodegenerative diseases, e.g., Alzheimer's disease; cardiovascular disorders; viricides; fungicides |
| 01/03/2002 | US20020002176 Apomorphine and norapomorphine N-glucuronides, O-sulfates, O-glucuronides, N-sulfates, O-phosphates and N-phosphates, esters, ethers, and N-alkyls; sexual disorders and Parkinson's disease; bioavailability; side effect reduction |
| 01/03/2002 | US20020002175 Nasal delivery of apomorphine in combination with glycol derivatives |
| 01/03/2002 | US20020002174 Serotonin antagonists |
| 01/03/2002 | US20020002173 E. g., 6-(3-chlorophenyl)-1,4-dihydro-4,4-dimethyl-2H-thieno-(2,3-d)(1,3)oxazine-2 -one; agonists and antagonists of the progesterone receptor; inducing contraception and treating or preventing benign or malignant neoplastic diseases |
| 01/03/2002 | US20020002172 Pharmaceutical formulations |
| 01/03/2002 | US20020002171 Materials and methods for killing nematodes and nematode eggs |
| 01/03/2002 | US20020002170 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
| 01/03/2002 | US20020002169 Protein kinase inhibitors |
| 01/03/2002 | US20020002168 Heterocyclic carboxamides |
| 01/03/2002 | US20020002166 Use of MKC-442 in combination with other antiviral agents |
| 01/03/2002 | US20020002165 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 01/03/2002 | US20020002164 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/03/2002 | US20020002163 1,4-benzodiazepinones and their uses as CCK antagonists |
| 01/03/2002 | US20020002162 Synergistic methods and compositions for treating cancer |
| 01/03/2002 | US20020002161 5-HT ligands used to treat central nervous system disorders |
| 01/03/2002 | US20020002160 Process for formulation of antibiotic compounds |
| 01/03/2002 | US20020002159 Use of beta-lactamase inhibitors as neuroprotectants |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002157 Salen-metal complexes having superoxide, catalase and/or peroxidase activity to treat or prevent diseases from cell or tissue damage |
| 01/03/2002 | US20020002156 Androgenic steroid compounds and a method of making and using the same |
| 01/03/2002 | US20020002155 Glucocorticoids; antiimflammatory and immunosuppressive agents |
| 01/03/2002 | US20020002154 Method and composition for treatment of inflammatory conditions |
| 01/03/2002 | US20020002153 Gonadotropin releasing hormone(GnRHa); 17-alpha-estradiol and its chemically modified derivatives, as well as those of 17-beta-estradiol and estriol |
| 01/03/2002 | US20020002151 Minocycline-containing compositions |
| 01/03/2002 | US20020002150 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 01/03/2002 | US20020002149 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors |
| 01/03/2002 | US20020002147 Stabilizing amount of magnesium stearate; extended dosage formed by extrusion and spheronization and coated with a seal coating; nucleoside reverse transcriptase inhibitor; treatment of retroviruses, HIV |
| 01/03/2002 | US20020002146 Compositions and methods for the production of S-adenosylmethionine within the body |
| 01/03/2002 | US20020002145 Adenosine A2A receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
| 01/03/2002 | US20020002144 Contacting acetyl coenzyme A with an alkylating derivative of an acetyl acceptor substrate in the presence of an acetyltransferase; antidepressants, analgesics, antipsychotics |
| 01/03/2002 | US20020002142 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| 01/03/2002 | US20020002141 For inhibiting apoptosis or apoptosis-like cell death |
| 01/03/2002 | US20020002140 Novel bisphosphonates and uses thereof |
| 01/03/2002 | US20020002139 Administering coniferylaldehyde, caffeic acid ethyl ester, sinapinalcohol, chlorogenic acid, eleutheroside B,B1,E,A, 6,8-dimethoxy-7-hydroxycoumarin, syrinagresinol, for modulating immune system |
| 01/03/2002 | US20020002138 For use in treatment of diseases associated with reduced levels of growth hormone |
| 01/03/2002 | US20020002137 Combination of growth hormone secretagogues and antidepressants |
| 01/03/2002 | US20020002135 Pharmaceutical use |
| 01/03/2002 | US20020001640 Method for improving bone modeling and chondrocyte functioning in growing canines |
| 01/03/2002 | US20020001631 Human growth hormone |
| 01/03/2002 | US20020001629 Pretreatment; inducing stress response |
| 01/03/2002 | US20020001622 By blending redried corn starch, silica and at least one vitamin in a blender in any order to make a dry, free-flowing powder; economical method |
| 01/03/2002 | US20020001621 By using a variety of polymers, having varying starting molecular weights, by varying the hold time of the nucleophilic compound/polymer solution; encapsulated active agents |
| 01/03/2002 | US20020001616 Novel method of treatment |
| 01/03/2002 | US20020001612 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 01/03/2002 | US20020001611 The latter for stability in aqueous medium, for human consumption |
| 01/03/2002 | US20020001608 Biodegradable implant precursor |
| 01/03/2002 | US20020001607 Perfluoroalkane or fluorohydrocarbons deoxygenated which prevents their damage to the retina or intraocular structures; use such as treating ischemic retinal disorders |
| 01/03/2002 | US20020001598 Pharmaceutical microspheres containing valproic acid for oral administration |
| 01/03/2002 | US20020001591 Compositions for the delivery of antigens |
| 01/03/2002 | US20020001574 Inserting a polynucleotide selecated from DNA, RNA containing a viral vector into a vessel having a permeable wall and increasing the permeability of the wall for a time sufficent to allow delivery of the polynucleotide to the muscle cells |
| 01/03/2002 | US20020001573 Immunostimulator anti-cancer compounds |
| 01/03/2002 | US20020001567 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 01/03/2002 | US20020001565 Radioprotective agents |
| 01/03/2002 | US20020001259 Slider for optical head, method for preparation thereof and recording and/or reproducing apparatus |
| 01/03/2002 | DE10030891A1 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation |
| 01/03/2002 | DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL |
| 01/03/2002 | DE10029371A1 Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka Heterocyclic Aminoalkylpyridinderivate as psychotropic drugs |
| 01/03/2002 | DE10028204A1 Verfahren zur Auffindung von medizinisch wertvollen Wirkstoffen Method for identifying medically valuable active ingredients |
| 01/03/2002 | DE10027928A1 Use of fatty acid oligoethylene glycol ester derivatives for treating bacterial infections and as bactericides, preservatives and disinfectants |
| 01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
| 01/03/2002 | CA2417699A1 Helicobacter pylori heptosyl transferase polypeptides |
| 01/03/2002 | CA2417692A1 Helicobacter dd-heptosyltransferase |
| 01/03/2002 | CA2417552A1 Compositions and methods for treating females sexual response |
| 01/03/2002 | CA2415873A1 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 01/03/2002 | CA2414678A1 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 01/03/2002 | CA2414512A1 Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 01/03/2002 | CA2414409A1 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 01/03/2002 | CA2414406A1 Use of egf-r protein tyrosine kinase inhibitors for preventing photoaging in human skin |
| 01/03/2002 | CA2414401A1 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 01/03/2002 | CA2414389A1 Methods of treating neutrophil-related diseases with topical anesthetics |
| 01/03/2002 | CA2414150A1 Modified forms of nonsteroidal anti-inflammatory drugs and uses thereof |
| 01/03/2002 | CA2414115A1 Indole derivatives useful for the treatment of cns disorders |
| 01/03/2002 | CA2414089A1 Improvements in and relating to chromophores |
| 01/03/2002 | CA2413816A1 Controlled release arginine formulations |
| 01/03/2002 | CA2413768A1 Pharmaceutical compositions for angiogenic therapy |
| 01/03/2002 | CA2413752A1 Substituted phthalides as anti-convulsive drugs |
| 01/03/2002 | CA2413702A1 Carvedilol |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |